You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Goal Guide: A Web-Based Application for Self-Management of Goal Tracking

    SBC: ASSISTECH SYSTEMS LLC            Topic: N/A

    This is a Phase II project to develop and evaluate the effectiveness of a responsively designed web application, Goal Guide, that enables individuals with intellectual disabilities and autism to effectively manage self-defined goals for everyday living across personal, educational, and vocational life domains. Users will be able to easily enter goals, work with data for each goal, engage with info ...

    SBIR Phase II 2014 Department of Education
  2. IGF::OT::IGF-- Biomarkers for Alcohol and ALD

    SBC: ECHELON BIOSCIENCES, INC.            Topic: NIAAA

    This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Business Innovation Research (SBIR) contract topic on Biomarkers for Alcohol-induced Disorders. The goals of this contract are to advance the usefulness of phosphatidylethanol (PEth), an alcohol metabolit ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. IGF::OT::IGF SBIR Topic 66 Phase II: Haptoglobin Treatment to Reduce Complications of Sickle Cell Disease

    SBC: NANOSHELL COMPANY, LLC            Topic: NHLBI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Single Well Avidity EIA to Determine Recency of HIV-1 Infections

    SBC: SEDIA BIOSCIENCES CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The objectives of this project are to develop a commercial single well HIV-1 Limiting Antigen Avidity EIA, developed in Phase I as a research tool, and establish its suitability for identifying recent HIV-1 infections on both a population an on an individual clinical basis as an aid to early intervention in acute infections. Such methods are needed for accurate ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Therapeutic Thrombin Analogs

    SBC: ARONORA INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Project Summary/Abstract Treatment of acute ischemic stroke (AIS) with the thrombolytic/antithrombotic agent tissue plasminogen activator (tPA, Activase(R)) is limited due to the potential for severe hemorrhagic side effects. The first symptoms of acute ischemia to tPA treatment ( time to needle ) can span hours, even in developed urban areas, since an establis ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Epoch Telemetry System for Long-Term Monitoring of Biopotentials

    SBC: EPITEL, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): Epoch Telemetry System for Long-Term Monitoring of Biopotentials ABSTRACT Epoch is a wireless, multi- channel biopotential recording system designed for small animal translational research models of human disease developed in Phase I and II. Obtaining long- term continuous recordings from animal models of disease is a critical component of translational resear ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. IGF::OT::IGF Novel siRNA-nanoparticle Platform for Treating Drug-Resistant HER2 Positive Breast Cancer

    SBC: PDX PHARMACEUTICALS, INC.            Topic: NCI

    Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted therapies, including Herceptin and lapatinib, account for 55% of the breast cancer therapy market in 2011 (or $5 billion annually). Response to HER2-targeted therapies typically average about one year ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Covert Optically-Reporting Threat-Functionalized Nanomaterials

    SBC: VOXTEL, INC.            Topic: DTRA122003

    To address the limitations of diagnostic equipment for chemical and biological warfare agent threats, Voxtel proposes to further develop low-cost, rapid biological-threat-reporting optical nanomaterials for a tag-track-and-locate system to consistsing of five components: 1) nanocrystal nanobeacons, a series of covert threat-functionalized optical identifiers with near-infrared through short-wave i ...

    SBIR Phase II 2014 Department of DefenseDefense Threat Reduction Agency
  9. Chitosan Endoluminal Hemostatic Dressing

    SBC: HemCon Medical Technologies Inc            Topic: 400

    DESCRIPTION provided by applicant Perioperative hemorrhage remains the major complication of transurethral and open prostatic surgical procedures Significant blood loss from these procedures causes delayed healing and longer hospitalization which significantly increases the cost of patient care Moreover prolonged urethral catheterization due to significant post operative hematuria is one of ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. RADIOGRAPHIC CONTRAST TO DIFFERENTIATE CAVITATED FROM NON-CAVITATED DENTAL CARIES

    SBC: FIREFLY HEALTH INNOVATIONS NE, INC.            Topic: NIDCR

    DESCRIPTION provided by applicant This project aims to improve the accuracy of tests for early tooth decay dental caries specifically for interproximal surfaces where the posterior teeth abut one another In these regions there is no physical space to visually inspect or probe for caries Instead dentists rely on bitewing X rays BWs But dentists cannot tell whether lucencies observed ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government